Literature DB >> 7869409

Pseudopapillary fibroelastoma of the mitral valve.

E Madu1, J Myles, T D Fraker.   

Abstract

Papillary fibroelastomas are well-recognized benign cardiac neoplasms. They are primarily asymptomatic, but occasionally are associated with neurologic and cardiac symptoms. Pseudopapillary fibroelastomas presenting with usual clinical and echocardiographic manifestations of papillary fibroelastoma but lacking characteristic histologic features have not been described previously. This article describes a 42-year-old, previously healthy female admitted with sudden hemiparesis and dysarthria. Symptoms completely resolved within 4 days. Extensive investigations revealed no etiology except for a pedunculated mitral valve mass with echocardiographic appearance suggestive of papillary fibroelastoma. Histologic staining, however, failed to reveal characteristic features of papillary fibroelastoma.

Entities:  

Mesh:

Year:  1995        PMID: 7869409      PMCID: PMC2607743     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  Fact and fiction about management of aortic transection.

Authors:  K L Mattox
Journal:  Ann Thorac Surg       Date:  1989-07       Impact factor: 4.330

2.  Cardiac papillary fibroelastomas. Two-dimensional echocardiographic recognition.

Authors:  C Shub; A J Tajik; J B Seward; W D Edwards; R D Pruitt; T A Orszulak; J R Pluth
Journal:  Mayo Clin Proc       Date:  1981-10       Impact factor: 7.616

3.  Cardiac papillary fibroelastoma and stroke. Echocardiographic diagnosis and guide to excision.

Authors:  E J Topol; R O Biern; B A Reitz
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

  3 in total
  1 in total

1.  Nonsurgical management of a tricuspid valvular pedunculated papillary fibroelastoma.

Authors:  Sang-Hoon Seol; Dong-Soo Kim; Yang-Chun Han; Ki-Hun Kim; Young-Bok Kim; Dong-Kie Kim; Tae-Hyun Yang; Dae-Kyeong Kim; Doo-Il Kim
Journal:  Cardiovasc Ultrasound       Date:  2009-09-04       Impact factor: 2.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.